Outcomes based on Albumin-Bilirubin (ALBI) grade in the phase 3 CELESTIAL trial of cabozantinib versus placebo in patients with advanced hepatocellulat carcinoma (HCC)

Basit Öğe Kaydı
dc.authoridCicin, Irfan/0000-0002-7584-3868
dc.authorwosidCicin, Irfan/AAQ-5575-2020
dc.contributor.authorMiksad, R.
dc.contributor.authorCicin, I.
dc.contributor.authorChen, Y.
dc.contributor.authorKlumpen, H.
dc.contributor.authorKim, S.
dc.contributor.authorLin, Z.
dc.contributor.authorYoukstetter, J.
dc.date.accessioned2024-06-12T11:24:02Z
dc.date.available2024-06-12T11:24:02Z
dc.date.issued2019
dc.departmentTrakya Üniversitesien_US
dc.descriptionEuropean-Society-for-Medical-Oncology (ESMO) 21st World Congress on Gastrointestinal Cancer -- JUL 03-06, 2019 -- Barcelona, SPAINen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipEuropean Soc Med Oncolen_US
dc.identifier.endpage134en_US
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.startpage134en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/26785
dc.identifier.volume30en_US
dc.identifier.wosWOS:000475860200021en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofAnnals Of Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleOutcomes based on Albumin-Bilirubin (ALBI) grade in the phase 3 CELESTIAL trial of cabozantinib versus placebo in patients with advanced hepatocellulat carcinoma (HCC)en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu